Респираторная инфекция и роль сывороточных биомаркеров при обострении атопической бронхиальной астмы
https://doi.org/10.18093/0869-0189-2010-3-46-52
Аннотация
респираторной инфекции. Был обследован 31 человек - 4 мужчины и 27 женщин (средний возраст - 50,4 ± 13,5 лет). У больных с обострением атопической БА на фоне респираторной инфекции в результате комплексной микробиологической оценки было выявлено, что
причиной обострения являлись вирусная (29,0 %), бактериальная (45,2 %) инфекция и ассоциации микроорганизмов (25,8 %). Уровень
С-реактивного белка достоверно повышался у больных с бактериальной инфекцией, в то время как уровень интерферона- был достоверно снижен у пациентов с вирусной инфекцией, что свидетельствовало о диагностической значимости в этиологии обострения болезни. При сравнении сывороточных уровней данных цитокинов в исследуемых группах больных статистически значимой разницы не обнаружено.
Ключевые слова
УДК 616.248-06
Об авторах
Г. Э. ХаптхаеваРоссия
А. Г. Чучалин
Россия
А. А. Пустовалов
Россия
К. А. Зыков
Россия
Н. А. Колганова
Россия
Список литературы
1. Глобальная стратегия лечения и профилактики бронхи альной астмы (GINA). Пер. с англ. М.: Атмосфера; 2006.
2. Авдеев С.Н. Обострение бронхиальной астмы. В кн.: Чуча лин А.Г. (ред.). Клинические рекомендации. Бронхиальная астма. М.: Изд. дом "Атмосфера"; 2008. 120-140.
3. Pauwels R.A., Pedersen S., Busse W.W. et al. START Investi gators Group. Early intervention with budesonide in mild persistent asthma: a randomised, doubleblind trial. Lancet 2003; 361: 1071-1076.
4. Johnston S.L., Pattemore P.K., Sanderson G. et al. Community study of the role of viral infections in exacerbations of asthma in 9-11 year old children. Br. Med. J. 1995; 310: 1225-1228.
5. Wennergren G., Kristjánsson S. Relationship between respirato ry syncytial virus bronchiolitis and future obstructive airways diseases. Eur. Respir. J. 2000; 13: 1044-1058.
6. Savykoskia T., Harjub T., Paldaniusa M. et al. Chlamydia pneu moniae infection and inflammation in adults with asthma. Respiration 2004; 71: 120-125
7. Hahn D.L., Dodge R.W., Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult onset asthma. J.A.M.A. 1991; 266: 225-230.
8. Black P.N., Scicchitano R., Jenkins C.R. et al. Serological evi dence of infection with Chlamydia pneumonia is related to the severity of asthma. Eur. Respir. J. 2000; 15: 254-259.
9. Cunningham A.F., Johnston S.L., Julious S.A. et al. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur. Respir. J. 1998; 11: 345-349.
10. Message S.D., Laza:Stanca V., Mallia P. et al. Rhinovirus induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL10 production. Proc. Natl. Acad. Sci. USA. 2008;105 (36): 13562-13567.
11. Wark P.A.B., Johnston S.L., Bucchieri F. et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 2005; 201: 937-947.
12. Jousilahti P., Salomaa V., Hakala K. et al. The association of sensitive systemic inflammation markers with bronchial asthma. Ann. Allergy Asthma Immunol. 2002; 89: 381-385.
13. Murray P.R., Washington J.A. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin. Proc. 1975; 50: 339-344.
14. Johnston S.L., Pattemore P.K., Sanderson G. et al. The relationship between upper respiratory infections and hospital admis sions for asthma: a timetrend analysis. Am. J. Respir. Crit. Care Med. 1996; 154: 654-660.
15. Johnston S.L., Pattemore P.K., Sanderson G. et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Br. Med. J. 1995; 310: 1225-1229.
16. Wark P.A., Johnston S.L., Moric I. et al. Neutrophil degranulation and cell lysis is associated with clinical severity in virus induced asthma. Eur. Respir. J. 2002; 19: 68-75.
17. Grissell T.V., Powell H., Shaffren D.R. et al. Interleukin10 gene expression in acute virusinduced asthma. Am. J. Respir. Crit. Care Med. 2005; 172: 433-439.
18. Carlsen K.H., Orstavik I., Lecgaard J. et al. Respiratory virus infections and aeroallergens in acute bronchial asthma. Arch. Dis. Childh. 1984; 59: 310-315.
19. Papi A., Papadopoulos N.G., Stanciu L.A. et al. Reducing agents inhibit rhinovirusinduced upregulation of the rhinovirus receptor intercellular adhesion molecule1 (ICAM1) in respi ratory epithelial cells. FASEB J. 2002; 16: 1934-1936.
20. Teichtahl H., Buckmaster N., Pertnikovs E. The incidence of respiratory tract infection in adults requiring hospitalization for asthma. Chest 1997; 112: 591-596.
21. Swineford O., Holman J. Studies in bacterial allergy, III. Results of 3860 cutaneous tests with 34 crude polysaccharide and nucleoprotein fractions of 14 different bacteria. J. Allergy 1949, 20: 420-427.
22. Thomas W.S., Touart M.D. Treatment of asthma with autogenous vaccines. Arch. Intern. Med. 1924; 34: 79-84.
23. Hudgel D.W., Langston L. Jr., Selner J.C., McIntosh K. Viral and bacterial infections in adults with chronic asthma. Am. Rev. Respir. Dis. 1979; 120: 393-397.
24. McIntosh K., Ellis E.F., Hoffman L.S. et al. The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J. Pediatr. 1973; 82: 578-590.
25. Graham V.A., Milton A.F., Knowles G.K., Davies R.J. Routine antibiotics in hospital management of acute asthma. Lancet 1982; 1: 418-420.
26. Shapiro G.G., Eggleston P.A., Pierson W.E. et al. Doubleblind study of the effectiveness of a broad spectrum antibiotic in status asthmaticus. Pediatrics 1974, 53: 867-872.
27. Kraft M., Cassell G.H., Pak, J., Martin R.J. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: Effect of clarithromycin. Chest 2002; 121: 1782-1788.
28. Vojta P.J., Friedman W., Marker D.A. et al. First National Survey of Lead and Allergens in Housing: Survey design and methods for the allergen and endotoxin components. Environ. Hlth Perspect. 2002; 110: 527-532.
29. Corne J.M., Marshall C., Smith S. et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and nonasthmatic individuals: a longitudinal cohort study. Lancet 2002; 359: 831-834.
30. Yoon H.J., Zhu Z., Gwaltney J.M. Jr., Elias J.A. Rhinovirus regulation of IL1 receptor antagonist in vivo and in vitro: a poten tial mechanism of symptom resolution. J. Immunol. 1999; 162: 7461-7469.
31. Zhu Z., Tang W., Gwaltney J.M.Jr. et al. Rhinovirus stimulation of interleukin8 in vivo and in vitro: role of NFkappaB. Am. J. Physiol. 1997; 273: L814-L824.
32. Zhu Z., Tang W., Ray A. et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro: evidence for nuclear factor B dependent transcriptional activation. J. Clin. Invest. 1996; 97: 421-430.
33. Papi A., Johnston S.L. Respiratory epithelial cell expression of vascular cell adhesion molecule1 and its upregulation by rhi novirus infection via NFkappaB and GATA transcription factors. J. Biol. Chem. 1999; 274: 30041-30051.
34. Papi A., Johnston S.L. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM1) via increased NFkappaBmediated transcription. J. Biol. Chem. 1999; 274: 9707-9720.
35. Kim J., Sanders S.P., Siekierski E.S. et al. Role of NFkappa B in cytokine production induced from human airway epithelial cells by rhinovirus infection. J. Immunol. 2000; 165: 3384-3392.
36. Johnston S.L. Overview of virusinduced airway disease. Proc. Am. Thorac. Soc. 2005; 2: 150-156.
37. Trautmann A., Schmid:Grendelmeier P., Kruger K. et al. T cells and eosinophils cooperate in the induction of bronchial epithe lial cell apoptosis in asthma. J. Allergy Clin. Immunol. 2002; 109: 329-337.
38. Papadopoulos N.G., Stanciu L.A., Papi A. et al. A defective type 1 response to rhinovirus in atopic asthma. Thorax 2002; 57: 328-332.
39. Castro M., Schweiger T., Yin:DeClue H. et al. Cytokine response after severe respiratory syncytial virus bronchiolitis in early life. J. Allergy Clin. Immunol. 2008; 122: 726-733.
40. Lacoma A., Prat C., Andreo F., DomInguez J. Biomarkers in the management of COPD. Eur. Respir. Rev. 2009; 18 (112): 96-104.
41. Olafsdottir I. S., Gislason T., Thjodleifsson B. et al. C reactive protein levels are increased in nonallergic but not in allergic asthma: a multicentre epidemiological study. Thorax 2005; 60: 451-454.
42. Kony S., Zureik M., Driss F. et al. Association of bronchial hyperresponsiveness and lung function with Creactive protein (CRP): a population based study. Thorax 2004; 59: 892-896.
43. Panaszek B., Liebhart E., Liebhart J. et al. Serum concentration of C-reactive protein is not a good marker of bronchial hyper responsiveness. Arch. Immunol. Ther. Exp. 2007; 55: 341-345.
44. Fujita M., Ueki S., Ito W. et al. Creactive protein levels in the serum of asthmatic patients. Ann. Allergy Asthma Immunol. 2007; 99 (1): 48-53.
45. Kasayama S., Tanemura M., Koga M. et al. Asthma is an inde pendent risk for elevation of plasma Creactive protein levels. Clin. Chim. Acta 2009; 399 (1-2): 79-82.
Рецензия
Для цитирования:
Хаптхаева Г.Э., Чучалин А.Г., Пустовалов А.А., Зыков К.А., Колганова Н.А. Респираторная инфекция и роль сывороточных биомаркеров при обострении атопической бронхиальной астмы. Пульмонология. 2010;(3):46-52. https://doi.org/10.18093/0869-0189-2010-3-46-52